Vishal Vashistha, MD

Article

A Case Series of Rare Immune-Mediated Adverse Reactions at the New Mexico Veterans Affairs Medical Center

Author:: Kenneth M. Zabel, MD; Lauren Tagliaferro-Epler, MD; Coty Ho, MD; Marissa Tafoya, MD; Michael Reyes, MD; Vishal Vashistha, MD

Immune checkpoint inhibitors (ICIs), often broadly referred to as immunotherapy, are being prescribed at increasing rates due to their...

Read More

Article

Sequential Targeted Treatment for a Geriatric Patient with Acute Myeloid Leukemia with Concurrent FLT3-TKD and IDH1 Mutations

Author:: Ryan S. Chiang, MD; Daphne R. Friedman, MD; Kelsey McHugh, MD; Sendhilnathan Ramalingam, MD; Vishal Vashistha, MD

Targeting and monitoring several acute myeloid leukemia mutations sequentially provides insights into optimal treatment plans.

Read More

Article

Sequential Targeted Treatment of an Elderly Patient With Acute Myeloid Leukemia Harboring Concurrent FLT3-TKD and IDH1 Mutations: A Case Report

Author:: Ryan S. Chiang, MD; Daphne R. Friedman, MD; Kelsey McHugh, MD; Sendhilnathan Ramalingam, MD; Vishal Vashistha, MD

Publish date: September 2, 2020

Read More

Article

DNA Repair Gene Variants in Patients With Prostate Cancer Achieving Durable Clinical Benefit With PARP Inhibitors

Author:: Meghan Price, BS; Vishal Vashistha, MD; David Winski, PhD; Rhonda Bitting, MD; Bruce Montgomery, MD; Michael Kelley, MD

Publish date: September 1, 2020

Read More

Article

In reply: Serotonin syndrome

Author:: Vishal Vashistha, MD; Robert Z. Wang, MD; Sukhdeep Kaur, MD; Gregory Rutecki, MD

Dr. Rose asks important clinical questions, but evidence-based answers are not available.

Read More

Article

Serotonin syndrome: Preventing, recognizing, and treating it

Author:: Robert Z. Wang, MD; Vishal Vashistha, MD; Sukdeep Kaur, MBBS; Nathan W. Houchens, MD

Serotonin syndrome can be easily overlooked, misdiagnosed, or exacerbated. Early recognition is critical.

Read More